| 1.9 |
9.6 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 1.4 |
7.2 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 1.1 |
6.6 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.8 |
2.5 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.6 |
1.2 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 0.6 |
1.7 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.6 |
1.7 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.6 |
1.7 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.5 |
1.5 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.5 |
1.4 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.5 |
4.5 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.4 |
2.2 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.4 |
2.6 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.4 |
1.3 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.4 |
1.3 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 |
1.2 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.4 |
1.6 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.4 |
1.6 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.4 |
1.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.4 |
2.2 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.4 |
0.4 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.4 |
1.1 |
GO:1903726 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.3 |
1.0 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.3 |
1.0 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) cardiac cell fate determination(GO:0060913) |
| 0.3 |
1.0 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 |
1.0 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.3 |
1.0 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 0.3 |
1.0 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.3 |
1.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.3 |
0.6 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.3 |
0.6 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.3 |
1.5 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 0.3 |
1.5 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.3 |
0.9 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.3 |
0.9 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.3 |
1.1 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.3 |
1.1 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.3 |
1.1 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 |
0.8 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.2 |
0.2 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.2 |
2.5 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 |
2.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
1.0 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.2 |
1.2 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 |
0.7 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.2 |
1.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
0.7 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.2 |
0.7 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
0.4 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.2 |
0.9 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.2 |
1.5 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
0.2 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.2 |
0.4 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 |
2.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
0.6 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.2 |
1.0 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.2 |
0.8 |
GO:0060266 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.2 |
0.4 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.2 |
0.8 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 |
1.8 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.2 |
0.2 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.2 |
0.6 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 |
0.2 |
GO:0071560 |
cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.2 |
0.6 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.2 |
0.9 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.2 |
0.9 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 |
1.1 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.2 |
0.5 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.2 |
1.4 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.2 |
1.7 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.5 |
GO:0097252 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of fermentation(GO:0043465) oligodendrocyte apoptotic process(GO:0097252) negative regulation of fermentation(GO:1901003) |
| 0.2 |
1.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
0.3 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.2 |
0.5 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.2 |
0.7 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
0.5 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.2 |
0.3 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.2 |
0.8 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.2 |
0.5 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.2 |
0.5 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.2 |
1.6 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.2 |
1.2 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 |
0.6 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.2 |
0.6 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.2 |
0.8 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.2 |
0.8 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.1 |
2.7 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 |
0.9 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
0.9 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.1 |
0.6 |
GO:0048819 |
positive regulation of keratinocyte proliferation(GO:0010838) regulation of hair follicle maturation(GO:0048819) regulation of catagen(GO:0051794) |
| 0.1 |
0.6 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
1.0 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
0.4 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
2.3 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.1 |
1.0 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.1 |
1.2 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.1 |
1.0 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.1 |
0.8 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.8 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.4 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.1 |
0.4 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.1 |
0.7 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
2.2 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
1.3 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.1 |
0.4 |
GO:0086069 |
desmosome assembly(GO:0002159) response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 |
0.4 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 |
0.2 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.1 |
0.6 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.1 |
0.6 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
1.9 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.3 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.1 |
0.3 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.7 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.3 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
0.2 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
0.4 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 |
1.9 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 |
0.8 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
0.9 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
0.9 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.4 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.1 |
0.3 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.1 |
0.3 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
0.3 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.1 |
0.7 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.1 |
0.3 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
0.7 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
0.4 |
GO:1904995 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 |
0.9 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.5 |
GO:0021984 |
adenohypophysis development(GO:0021984) |
| 0.1 |
0.4 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.5 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.1 |
0.9 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.8 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.1 |
1.5 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.3 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 |
0.6 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.8 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.3 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.1 |
1.3 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.5 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
1.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.8 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
0.5 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.4 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.2 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 |
0.2 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 |
0.7 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 |
0.3 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.1 |
0.6 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
0.6 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.2 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 |
0.1 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.1 |
1.0 |
GO:0031114 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.1 |
0.5 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 |
0.6 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 |
0.3 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.4 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.1 |
0.2 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
0.4 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 |
0.5 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 |
0.4 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
0.3 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.4 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 |
0.1 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
0.5 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 |
1.1 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.2 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.6 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.1 |
0.3 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
1.0 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.1 |
0.2 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.1 |
0.2 |
GO:0035928 |
RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
0.8 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.2 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.1 |
0.3 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
1.2 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
1.3 |
GO:0002718 |
regulation of cytokine production involved in immune response(GO:0002718) |
| 0.1 |
0.2 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 |
0.7 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
0.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
1.1 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.1 |
0.2 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.2 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 |
0.1 |
GO:0035793 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.1 |
0.3 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.7 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.1 |
0.1 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 0.1 |
0.1 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 |
0.3 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
0.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.1 |
0.4 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.1 |
0.2 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
0.3 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.1 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.1 |
1.9 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.5 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.4 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.1 |
0.1 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.4 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
1.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-dependent nucleosome organization(GO:0034723) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 |
0.3 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
0.6 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.2 |
GO:0071594 |
T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.0 |
0.2 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.0 |
0.3 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.0 |
0.8 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.2 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.0 |
0.3 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 |
0.8 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
0.4 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.0 |
0.4 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.2 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
0.4 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.0 |
0.2 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.0 |
0.5 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.4 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 |
0.3 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.0 |
0.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.5 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.2 |
GO:0035993 |
deltoid tuberosity development(GO:0035993) |
| 0.0 |
0.2 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.0 |
0.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.2 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.4 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.2 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.0 |
0.7 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.4 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.1 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.0 |
0.2 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.1 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 |
1.3 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.0 |
0.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.5 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.0 |
0.3 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.0 |
0.3 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.2 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.0 |
0.2 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.0 |
0.3 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.0 |
0.7 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.0 |
0.1 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.5 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.0 |
0.2 |
GO:1903867 |
chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
| 0.0 |
1.3 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
1.5 |
GO:0051294 |
establishment of spindle orientation(GO:0051294) |
| 0.0 |
0.1 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.5 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.0 |
0.3 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.0 |
0.1 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.0 |
0.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
0.1 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.0 |
0.3 |
GO:0007063 |
regulation of sister chromatid cohesion(GO:0007063) |
| 0.0 |
0.2 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.3 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.0 |
2.7 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.7 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
1.1 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.7 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.1 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.0 |
1.0 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.6 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.1 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.4 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.0 |
0.8 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.4 |
GO:0045624 |
positive regulation of T-helper cell differentiation(GO:0045624) |
| 0.0 |
0.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.4 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.0 |
0.5 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 |
0.3 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
1.6 |
GO:0048709 |
oligodendrocyte differentiation(GO:0048709) |
| 0.0 |
0.2 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.0 |
0.4 |
GO:0010829 |
negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
| 0.0 |
0.3 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 |
0.2 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.5 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.7 |
GO:0032330 |
regulation of chondrocyte differentiation(GO:0032330) |
| 0.0 |
0.7 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.0 |
0.1 |
GO:0060677 |
ureteric bud elongation(GO:0060677) ureteric bud invasion(GO:0072092) |
| 0.0 |
0.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
1.7 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.6 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.6 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.3 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.2 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
0.7 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.0 |
0.3 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.2 |
GO:0060973 |
cell migration involved in heart development(GO:0060973) |
| 0.0 |
0.2 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
0.1 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.0 |
0.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.3 |
GO:0036376 |
sodium ion export from cell(GO:0036376) |
| 0.0 |
0.0 |
GO:1903406 |
regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.0 |
0.3 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 |
0.3 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.0 |
1.4 |
GO:0001889 |
liver development(GO:0001889) |
| 0.0 |
0.2 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.2 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.0 |
0.5 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.1 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.0 |
0.1 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.2 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.0 |
0.2 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.1 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.0 |
0.2 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.1 |
GO:0006023 |
aminoglycan biosynthetic process(GO:0006023) |
| 0.0 |
0.1 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 |
0.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.2 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
0.3 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.2 |
GO:0042438 |
melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.0 |
GO:2000780 |
negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.0 |
0.2 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.4 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.2 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.3 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.0 |
0.2 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 |
0.1 |
GO:0006848 |
pyruvate transport(GO:0006848) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.2 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.0 |
0.1 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.0 |
0.1 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.3 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.6 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.3 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
0.2 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.0 |
0.4 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 |
0.1 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.0 |
0.0 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.0 |
0.1 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.0 |
0.5 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.2 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.2 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.0 |
0.1 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.0 |
1.4 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 |
0.1 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.0 |
0.2 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.1 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
